APO RESEARCH · REPORT
Guaifenesin (API)
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Product & engineering
Understand the product.
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Selected research
Industry Research
Guaifenesin (API) Industry Research Report 2026
Market perspective
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Global Guaifenesin (API) key players include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific and North America is the largest market, both with a share about 35%, followed by Europe, with a share about 25 percent. In terms of product, Above 99% is the largest segment, with a share about 75%. And in terms of application, the largest application is Pharmaceuticals.
Report Scope
Read the full market overview
This report quantifies the global Guaifenesin (API) market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Guaifenesin (API) Market by Company
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Guaifenesin (API) Segment by Type
98%-99%
Above 99%
Guaifenesin (API) Segment by Application
Pharmaceuticals
Others
Guaifenesin (API) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Guaifenesin (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Guaifenesin (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Guaifenesin (API).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Guaifenesin (API) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Guaifenesin (API) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Guaifenesin (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 98%-99%
- Above 99%
Applications
- Pharmaceuticals
- Others
Companies covered
- Granules
- Synthokem Labs
- Haizhou Pharma
- Yuan Cheng Group
- Stellar Chemical
- Seven Star Pharma
- Gennex Lab
- Iwaki Seiyaku
- Pan Drugs
- Delta Synthetic
- Smart Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Guaifenesin (API) Market Size (2021-2032)
- 2.2.2 Global Guaifenesin (API) Sales (2021-2032)
- 2.2.3 Global Guaifenesin (API) Market Average Price (2021-2032)
- 2.3 Guaifenesin (API) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 98%-99%
- 2.3.3 Above 99%
- 2.4 Guaifenesin (API) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceuticals
- 2.4.3 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Guaifenesin (API) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Guaifenesin (API) Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Guaifenesin (API) Revenue of Manufacturers (2021-2026)
- 3.4 Global Guaifenesin (API) Average Price by Manufacturers (2021-2026)
- 3.5 Global Guaifenesin (API) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Guaifenesin (API), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Guaifenesin (API), Product Type & Application
- 3.8 Global Manufacturers of Guaifenesin (API), Established Date
- 3.9 Global Guaifenesin (API) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Granules
- 4.1.1 Granules Company Information
- 4.1.2 Granules Business Overview
- 4.1.3 Granules Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Granules Guaifenesin (API) Product Portfolio
- 4.1.5 Granules Recent Developments
- 4.2 Synthokem Labs
- 4.2.1 Synthokem Labs Company Information
- 4.2.2 Synthokem Labs Business Overview
- 4.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Synthokem Labs Guaifenesin (API) Product Portfolio
- 4.2.5 Synthokem Labs Recent Developments
- 4.3 Haizhou Pharma
- 4.3.1 Haizhou Pharma Company Information
- 4.3.2 Haizhou Pharma Business Overview
- 4.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Haizhou Pharma Guaifenesin (API) Product Portfolio
- 4.3.5 Haizhou Pharma Recent Developments
- 4.4 Yuan Cheng Group
- 4.4.1 Yuan Cheng Group Company Information
- 4.4.2 Yuan Cheng Group Business Overview
- 4.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Yuan Cheng Group Guaifenesin (API) Product Portfolio
- 4.4.5 Yuan Cheng Group Recent Developments
- 4.5 Stellar Chemical
- 4.5.1 Stellar Chemical Company Information
- 4.5.2 Stellar Chemical Business Overview
- 4.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Stellar Chemical Guaifenesin (API) Product Portfolio
- 4.5.5 Stellar Chemical Recent Developments
- 4.6 Seven Star Pharma
- 4.6.1 Seven Star Pharma Company Information
- 4.6.2 Seven Star Pharma Business Overview
- 4.6.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Seven Star Pharma Guaifenesin (API) Product Portfolio
- 4.6.5 Seven Star Pharma Recent Developments
- 4.7 Gennex Lab
- 4.7.1 Gennex Lab Company Information
- 4.7.2 Gennex Lab Business Overview
- 4.7.3 Gennex Lab Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Gennex Lab Guaifenesin (API) Product Portfolio
- 4.7.5 Gennex Lab Recent Developments
- 4.8 Iwaki Seiyaku
- 4.8.1 Iwaki Seiyaku Company Information
- 4.8.2 Iwaki Seiyaku Business Overview
- 4.8.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Iwaki Seiyaku Guaifenesin (API) Product Portfolio
- 4.8.5 Iwaki Seiyaku Recent Developments
- 4.9 Pan Drugs
- 4.9.1 Pan Drugs Company Information
- 4.9.2 Pan Drugs Business Overview
- 4.9.3 Pan Drugs Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pan Drugs Guaifenesin (API) Product Portfolio
- 4.9.5 Pan Drugs Recent Developments
- 4.10 Delta Synthetic
- 4.10.1 Delta Synthetic Company Information
- 4.10.2 Delta Synthetic Business Overview
- 4.10.3 Delta Synthetic Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Delta Synthetic Guaifenesin (API) Product Portfolio
- 4.10.5 Delta Synthetic Recent Developments
- 4.11 Smart Pharm
- 4.11.1 Smart Pharm Company Information
- 4.11.2 Smart Pharm Business Overview
- 4.11.3 Smart Pharm Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Smart Pharm Guaifenesin (API) Product Portfolio
- 4.11.5 Smart Pharm Recent Developments
5 Global Guaifenesin (API) Market Scenario by Region
- 5.1 Global Guaifenesin (API) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Guaifenesin (API) Sales by Region: 2021-2032
- 5.2.1 Global Guaifenesin (API) Sales by Region: 2021-2026
- 5.2.2 Global Guaifenesin (API) Sales by Region: 2027-2032
- 5.3 Global Guaifenesin (API) Revenue by Region: 2021-2032
- 5.3.1 Global Guaifenesin (API) Revenue by Region: 2021-2026
- 5.3.2 Global Guaifenesin (API) Revenue by Region: 2027-2032
- 5.4 North America Guaifenesin (API) Market Facts & Figures by Country
- 5.4.1 North America Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Guaifenesin (API) Sales by Country (2021-2032)
- 5.4.3 North America Guaifenesin (API) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Guaifenesin (API) Market Facts & Figures by Country
- 5.5.1 Europe Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Guaifenesin (API) Sales by Country (2021-2032)
- 5.5.3 Europe Guaifenesin (API) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Guaifenesin (API) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Guaifenesin (API) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Guaifenesin (API) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Guaifenesin (API) Market Facts & Figures by Country
- 5.7.1 South America Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Guaifenesin (API) Sales by Country (2021-2032)
- 5.7.3 South America Guaifenesin (API) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Guaifenesin (API) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Guaifenesin (API) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Guaifenesin (API) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Guaifenesin (API) Sales by Type (2021-2032)
- 6.1.1 Global Guaifenesin (API) Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Guaifenesin (API) Sales Market Share by Type (2021-2032)
- 6.2 Global Guaifenesin (API) Revenue by Type (2021-2032)
- 6.2.1 Global Guaifenesin (API) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Guaifenesin (API) Revenue Market Share by Type (2021-2032)
- 6.3 Global Guaifenesin (API) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Guaifenesin (API) Sales by Application (2021-2032)
- 7.1.1 Global Guaifenesin (API) Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Guaifenesin (API) Sales Market Share by Application (2021-2032)
- 7.2 Global Guaifenesin (API) Revenue by Application (2021-2032)
- 7.2.1 Global Guaifenesin (API) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Guaifenesin (API) Revenue Market Share by Application (2021-2032)
- 7.3 Global Guaifenesin (API) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Guaifenesin (API) Value Chain Analysis
- 8.1.1 Guaifenesin (API) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Guaifenesin (API) Production Mode & Process
- 8.2 Guaifenesin (API) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Guaifenesin (API) Distributors
- 8.2.3 Guaifenesin (API) Customers
9 Global Guaifenesin (API) Analyzing Market Dynamics
- 9.1 Guaifenesin (API) Industry Trends
- 9.2 Guaifenesin (API) Industry Drivers
- 9.3 Guaifenesin (API) Industry Opportunities and Challenges
- 9.4 Guaifenesin (API) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst